Linked Data API

Show Search Form

Search Results

1028321
star this property registered interest false more like this
star this property date less than 2018-12-18more like thismore than 2018-12-18
star this property answering body
Department for Education more like this
star this property answering dept id 60 more like this
unstar this property answering dept short name Education more like this
star this property answering dept sort name Education more like this
star this property hansard heading Music: Qualifications more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what assessment they have made of the consequences for mutual recognition of music qualifications if the UK leaves the EU without a deal. more like this
star this property tabling member printed
Lord Clement-Jones more like this
star this property uin HL12395 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-12-20more like thismore than 2018-12-20
star this property answer text <p>Music qualifications are not included in the EU Mutual Recognition of Professional Qualifications Directive. The EU only has supporting competence in education and there is no EU law on the recognition of academic qualifications.</p><p> </p> more like this
star this property answering member printed Viscount Younger of Leckie more like this
star this property question first answered
less than 2018-12-20T17:06:10.28Zmore like thismore than 2018-12-20T17:06:10.28Z
star this property answering member
4169
star this property label Biography information for Viscount Younger of Leckie more like this
star this property tabling member
3396
star this property label Biography information for Lord Clement-Jones remove filter
62428
star this property registered interest false more like this
star this property date less than 2014-06-17more like thismore than 2014-06-17
star this property answering body
Department for Business, Innovation and Skills more like this
star this property answering dept id 26 more like this
unstar this property answering dept short name Business, Innovation and Skills more like this
star this property answering dept sort name Business, Innovation and Skills more like this
star this property hansard heading Copyright more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what progress they are making on their consideration of (1) protection of metadata, (2) remedies against lookalikes, and (3) equalisation of penalties for physical and digital copyright infringement. more like this
star this property tabling member printed
Lord Clement-Jones more like this
star this property uin HL366 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2014-06-24more like thismore than 2014-06-24
star this property answer text <p> </p><p><strong>(1)</strong> The issue of protection of metadata was considered as part of the industry-led Copyright Hub project, to which the Government contributed initial funding. This involved key players seeking cross-industry agreement to help keep metadata with copyright works and resulted in the publication of a voluntary Code of Practice on Creating and Maintaining Metadata in Images. It is clearly important for industry to take up that code of practice, before Government could consider whether or not any further action may be appropriate.</p><p><strong> </strong></p><p><strong>(2) </strong>The Government is considering the case for granting a civil right of action to business against lookalike packaging, for which it launched a review of the Consumer Protection from Unfair Trading Regulations (CPRs). The Review commenced this spring, and the initial call for evidence closed on 19 May. The Government is keen to continue engaging with stakeholders on this issue; a structured roundtable has been scheduled for 14 July. The final report is expected to be published in October.</p><p> </p><p><strong>(3) </strong>The Intellectual Property Office has commissioned Inngot Ltd to carry out a review of the use of copyright infringement sanctions. The review has commenced and is expected to report in November. Data gathering for copyright infringement sentencing is already underway, with a broad range of industry stakeholders being consulted including trade bodies; IP rights owners and IP legal professionals. The Government will consider what further action is needed once the final report has been published.</p><p> </p><p> </p><p> </p>
star this property answering member printed Viscount Younger of Leckie more like this
star this property question first answered
less than 2014-06-24T16:32:44.7362771Zmore like thismore than 2014-06-24T16:32:44.7362771Z
star this property answering member
4169
star this property label Biography information for Viscount Younger of Leckie more like this
star this property tabling member
3396
star this property label Biography information for Lord Clement-Jones remove filter
46652
star this property registered interest false more like this
star this property date less than 2014-04-02more like thismore than 2014-04-02
star this property answering body
Cabinet Office more like this
star this property answering dept id 53 more like this
unstar this property answering dept short name Cabinet Office more like this
star this property answering dept sort name Cabinet Office more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what is their latest estimate of the number of job vacancies in the United Kingdom; and, of that figure, how many are (1) full-time, (2) part-time, and (3) zero-hours contracts, temporary or self-employed vacancies. more like this
star this property tabling member printed
Lord Clement-Jones more like this
star this property uin HL6530 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2014-04-10more like thismore than 2014-04-10
star this property answer text <p> </p><p>The information requested falls within the responsibility of the UK Statistics Authority. I have asked the Authority to reply.</p><p> </p> more like this
star this property answering member printed Lord Wallace of Saltaire more like this
star this property question first answered
less than 2014-04-10T12:00:00.00Zmore like thismore than 2014-04-10T12:00:00.00Z
star this property answering member
1816
star this property label Biography information for Lord Wallace of Saltaire more like this
star this property attachment
1
star this property file name HL6530 ONS.pdf more like this
unstar this property title ONS letter more like this
star this property tabling member
3396
star this property label Biography information for Lord Clement-Jones remove filter
389136
star this property registered interest false more like this
star this property date less than 2015-07-13more like thismore than 2015-07-13
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Cancer: Drugs more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government what criteria will be applied to select products for possible delisting from the Cancer Drugs Fund in July; and in particular what is the scoring system that will be used. more like this
star this property tabling member printed
Lord Clement-Jones more like this
star this property uin HL1322 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-07-22more like thismore than 2015-07-22
star this property answer text <p>The criteria and scoring system for reviewing the current listed drugs within the Cancer Drugs Fund (CDF) is outlined in the published CDF Standard Operating Procedure which is available at: www.england.nhs.uk/ourwork/pe/cdf/. These state that:</p><p> </p><p> </p><p> </p><p>“Decisions will be based on the National Cancer Drugs Fund Prioritisation Tool in conjunction with an assessment of median drug cost per patient. This evaluation will be completed for each drug/indication under consideration and will result in an overall score based on a number of factors, including:</p><p> </p><p>o evidence of clinical benefit e.g. progression free survival (PFS) and overall survival (OS)</p><p> </p><p>o quality of life (QOL)</p><p> </p><p>o toxicity</p><p> </p><p>o unmet need</p><p> </p><p>o median drug cost per patient</p><p> </p><p> </p><p> </p><p>Drugs on the National CDF List will be subject to an affordability test within the overall CDF budget, being added or removed according to their relative aggregate score using the National Cancer Drugs Fund Prioritisation Tool of clinical benefit in conjunction with the assessment of drug cost per patient. Drugs whose aggregate score is below the threshold applicable at the time will not be added/will be removed from the National CDF List.”</p><p> </p><p> </p><p> </p><p>A copy is attached.</p><p> </p><p> </p><p> </p><p>NHS England has advised that the Fund is re-prioritised on a regular basis so that the resources available are used to the best benefit of patients.</p><p> </p><p> </p><p> </p><p> </p>
star this property answering member printed Lord Prior of Brampton more like this
star this property grouped question UIN HL1323 more like this
star this property question first answered
less than 2015-07-22T16:36:50.213Zmore like thismore than 2015-07-22T16:36:50.213Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
star this property attachment
1
star this property file name HL1322 HL1323 CDF SOP.pdf more like this
unstar this property title Cancer Drug Fund SOP more like this
star this property tabling member
3396
star this property label Biography information for Lord Clement-Jones remove filter
389137
star this property registered interest false more like this
star this property date less than 2015-07-13more like thismore than 2015-07-13
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Cancer: Drugs more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government why they are reviewing the Cancer Drugs Fund list, given the January review; and whether any assessment has been made of the impact on patients of the frequency with which medicines on the Cancer Drugs Fund list are reviewed. more like this
star this property tabling member printed
Lord Clement-Jones more like this
star this property uin HL1323 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-07-22more like thismore than 2015-07-22
star this property answer text <p>The criteria and scoring system for reviewing the current listed drugs within the Cancer Drugs Fund (CDF) is outlined in the published CDF Standard Operating Procedure which is available at: www.england.nhs.uk/ourwork/pe/cdf/. These state that:</p><p> </p><p> </p><p> </p><p>“Decisions will be based on the National Cancer Drugs Fund Prioritisation Tool in conjunction with an assessment of median drug cost per patient. This evaluation will be completed for each drug/indication under consideration and will result in an overall score based on a number of factors, including:</p><p> </p><p>o evidence of clinical benefit e.g. progression free survival (PFS) and overall survival (OS)</p><p> </p><p>o quality of life (QOL)</p><p> </p><p>o toxicity</p><p> </p><p>o unmet need</p><p> </p><p>o median drug cost per patient</p><p> </p><p> </p><p> </p><p>Drugs on the National CDF List will be subject to an affordability test within the overall CDF budget, being added or removed according to their relative aggregate score using the National Cancer Drugs Fund Prioritisation Tool of clinical benefit in conjunction with the assessment of drug cost per patient. Drugs whose aggregate score is below the threshold applicable at the time will not be added/will be removed from the National CDF List.”</p><p> </p><p> </p><p> </p><p>A copy is attached.</p><p> </p><p> </p><p> </p><p>NHS England has advised that the Fund is re-prioritised on a regular basis so that the resources available are used to the best benefit of patients.</p><p> </p><p> </p><p> </p><p> </p>
star this property answering member printed Lord Prior of Brampton more like this
star this property grouped question UIN HL1322 more like this
star this property question first answered
less than 2015-07-22T16:36:50.337Zmore like thismore than 2015-07-22T16:36:50.337Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
star this property attachment
1
star this property file name HL1322 HL1323 CDF SOP.pdf more like this
unstar this property title Cancer Drug Fund SOP more like this
star this property tabling member
3396
star this property label Biography information for Lord Clement-Jones remove filter
389138
star this property registered interest false more like this
star this property date less than 2015-07-13more like thismore than 2015-07-13
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Cancer: Drugs more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government how much the Cancer Drugs Fund has overspent, in the light of the second review to remove treatments from the Cancer Drugs Fund list. more like this
star this property tabling member printed
Lord Clement-Jones more like this
star this property uin HL1324 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-07-22more like thismore than 2015-07-22
star this property answer text <p>NHS England has advised that the Cancer Drugs Fund (CDF) overspent by £135.7 million (against a budget of £280 million) in 2014-15.</p><p> </p><p> </p><p> </p><p>Reprioritisation of the national CDF list is necessary within 2015-16 to remain within the fixed budget allocated to the Fund, as stated within the CDF Standard Operating Procedures.</p><p> </p> more like this
star this property answering member printed Lord Prior of Brampton more like this
star this property question first answered
less than 2015-07-22T16:32:29.653Zmore like thismore than 2015-07-22T16:32:29.653Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
star this property tabling member
3396
star this property label Biography information for Lord Clement-Jones remove filter
389139
star this property registered interest false more like this
star this property date less than 2015-07-13more like thismore than 2015-07-13
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Cancer: Drugs more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government how long the revised Cancer Drugs Fund list will be available for patients and clinicians to access. more like this
star this property tabling member printed
Lord Clement-Jones more like this
star this property uin HL1325 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-07-21more like thismore than 2015-07-21
star this property answer text <p>The Government is committed to continuing to invest in the Cancer Drugs Fund.</p> more like this
star this property answering member printed Lord Prior of Brampton more like this
star this property question first answered
less than 2015-07-21T16:39:49.343Zmore like thismore than 2015-07-21T16:39:49.343Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
star this property tabling member
3396
star this property label Biography information for Lord Clement-Jones remove filter
389140
star this property registered interest false more like this
star this property date less than 2015-07-13more like thismore than 2015-07-13
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Cancer: Drugs more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government what discussions have taken place, if any, with NHS England about (1) the levels of unmet need in rare cancers, and (2) incremental innovation in rare cancers' treatment, during the process of assessing medicines for inclusion on the Cancer Drugs Fund. more like this
star this property tabling member printed
Lord Clement-Jones more like this
star this property uin HL1326 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-07-21more like thismore than 2015-07-21
star this property answer text <p>NHS England has advised that the current scoring system within the Cancer Drugs Fund makes provision for rarer cancers and unmet need where there is no recognised treatment available for a specific cancer. The clinical impact of innovation is considered by the clinical panel as part of the prioritisation process.</p><p> </p> more like this
star this property answering member printed Lord Prior of Brampton more like this
star this property question first answered
less than 2015-07-21T16:46:23.673Zmore like thismore than 2015-07-21T16:46:23.673Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
star this property tabling member
3396
star this property label Biography information for Lord Clement-Jones remove filter
453538
star this property registered interest false more like this
star this property date less than 2016-02-22more like thismore than 2016-02-22
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Cancer: Drugs more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government how many cancer medicines launched since June 2015 are available via the Cancer Drugs Fund. more like this
star this property tabling member printed
Lord Clement-Jones more like this
star this property uin HL6240 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2016-03-03more like thismore than 2016-03-03
star this property answer text <p>No new cancer medicines have been added to the national Cancer Drugs Fund (CDF) list since June 2015. As part of its work to reprioritise the Fund in 2015-16, NHS England took the decision not to consider new drugs for inclusion on the national CDF list.</p><p> </p><p>NHS England and the National Institute for Health and Care Excellence (NICE) recently consulted on draft proposals for the future direction of the Fund. The consultation outlines a new system, fully integrated into the NICE appraisal process, where the CDF becomes a transitional fund – with clear criteria for entry and exit.</p><p> </p><p>Clinicians continue to be able to apply for cancer drugs not on the national CDF list through the Individual Cancer Drugs Funding Request procedure.</p> more like this
star this property answering member printed Lord Prior of Brampton more like this
star this property question first answered
less than 2016-03-03T12:45:59.347Zmore like thismore than 2016-03-03T12:45:59.347Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
star this property tabling member
3396
star this property label Biography information for Lord Clement-Jones remove filter
453539
star this property registered interest false more like this
star this property date less than 2016-02-22more like thismore than 2016-02-22
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Cancer: Drugs more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government whether they have had discussions with NHS England and the National Institute for Health and Care Excellence about whether new medicines not accessible through the Cancer Drugs Fund since June 2015 will be prioritised for early review under the proposed new terms of that Fund. more like this
star this property tabling member printed
Lord Clement-Jones more like this
star this property uin HL6241 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2016-03-03more like thismore than 2016-03-03
star this property answer text <p>The Department has had regular discussions with the National Institute for Health and Care Excellence and NHS England about the future operation of the Cancer Drugs Fund, including arrangements for the assessment of cancer drugs that are not currently available through the Fund.</p> more like this
star this property answering member printed Lord Prior of Brampton more like this
star this property question first answered
less than 2016-03-03T12:46:54.017Zmore like thismore than 2016-03-03T12:46:54.017Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
star this property tabling member
3396
star this property label Biography information for Lord Clement-Jones remove filter